Literature DB >> 19542858

Laparoscopic versus open splenectomy for hypersplenism secondary to liver cirrhosis.

Jin-Hui Zhu1, Yue-Dong Wang, Zai-Yuan Ye, Ting Zhao, Yang-Wen Zhu, Zhi-Jie Xie, Jin-Ming Liu.   

Abstract

BACKGROUND: Since the first laparoscopic splenectomy (LS) in 1991, LS has become the gold standard for the removal of normal-to-moderately enlarged spleens in benign conditions. Compared with open splenectomy (OS), fewer postsurgical complications and better postoperative recovery were observed, but it is contraindicated for hypersplenism secondary to liver cirrhosis owing to technical difficulties associated with splenomegaly, well-developed collateral circulation, and increased risk of bleeding. With the improvements of laparoscopic technique, the concept is changing.
METHODS: OS and LS performed for hypersplenism secondary to liver cirrhosis at our institution were analyzed. Relationships between postoperative increases in platelet counts, white blood cell counts, hemoglobin, and liver function were examined. Perioperative data of LSs were compared with those of OSs, including operative time, blood loss, excised spleen weight, complications, and hospital stays.
RESULTS: A total of 216 splenectomies (135 OS and 81 LS) were performed from April 1999 to March 2007. Five laparoscopic cases were converted to open surgery owing to operative bleeding or bleeding of splenic fossa. The other 76 patients were performed LSs successfully. No major operative complications occurred. There was no operative death. Excised spleen weight >400 g was present in 56% of cases in this series. At 7 days postoperatively, the platelet counts, white blood cell counts, and hemoglobin significantly increased after open and laparoscopic surgeries, and increase of alanine aminotransferase, aspartate aminotransferase, total bilirubin, and directed bilirubin of LS were significantly different with open cases. Operation times of LS and OS were 2.9+/-0.7 hours and 2.6+/-0.6 hours, respectively. Blood losses were 150.6+/-135.4 mL and 633.8+/-340.3 mL (P<0.01), excised spleen weights were 585.7+/-184.6 g and 591.1+/-153.4 g (P>0.05), and hospital stay were 8.2+/-2.0 days and 11.9+/-3.8 days (P<0.01). Operative associated complications were noted in both LS and OS. Less blood loss, shorter hospital stay, and less impairment of liver function were observed in LS than OS.
CONCLUSIONS: LS is feasible, effective, and safe procedures for hypersplenism secondary to liver cirrhosis and contributes to less impairment of liver function, less blood loss, and shorter hospital stay.

Entities:  

Mesh:

Year:  2009        PMID: 19542858     DOI: 10.1097/SLE.0b013e3181a6ec7c

Source DB:  PubMed          Journal:  Surg Laparosc Endosc Percutan Tech        ISSN: 1530-4515            Impact factor:   1.719


  16 in total

Review 1.  Laparoscopic splenectomy for hypersplenism secondary to liver cirrhosis and portal hypertension.

Authors:  Xiao-Li Zhan; Yun Ji; Yue-Dong Wang
Journal:  World J Gastroenterol       Date:  2014-05-21       Impact factor: 5.742

2.  A novel method for laparoscopic splenectomy in the setting of hypersplenism secondary to liver cirrhosis: ten years' experience.

Authors:  Yunqiang Cai; Xubao Liu; Bing Peng
Journal:  World J Surg       Date:  2014-11       Impact factor: 3.352

3.  Modified laparoscopic and open splenectomy and azygoportal disconnection for portal hypertension.

Authors:  Dou-Sheng Bai; Jian-Jun Qian; Ping Chen; Jie Yao; Xiao-Dong Wang; Sheng-Jie Jin; Guo-Qing Jiang
Journal:  Surg Endosc       Date:  2013-09-04       Impact factor: 4.584

4.  Hand-assisted laparoscopic splenectomy for thrombocytopenia in patients with cirrhosis.

Authors:  Keitaro Kakinoki; Keiichi Okano; Hironobu Suto; Minoru Oshima; Masanobu Hagiike; Hisashi Usuki; Akihiro Deguchi; Tutomu Masaki; Yasuyuki Suzuki
Journal:  Surg Today       Date:  2012-11-11       Impact factor: 2.549

5.  Laparoscopic splenectomy is an effective and safe intervention for hypersplenism secondary to liver cirrhosis.

Authors:  Yun Qiang Cai; Jin Zhou; Xiao Dong Chen; Yi Chao Wang; Zhong Wu; Bing Peng
Journal:  Surg Endosc       Date:  2011-06-17       Impact factor: 4.584

6.  Laparoscopic and open splenectomy for splenomegaly secondary to liver cirrhosis: an evaluation of immunity.

Authors:  Zhong Wu; Jin Zhou; Prasoon Pankaj; Bing Peng
Journal:  Surg Endosc       Date:  2012-06-19       Impact factor: 4.584

7.  A meta-analysis of perioperative outcomes of laparoscopic splenectomy for hematological disorders.

Authors:  Yan-Nan Bai; Hui Jiang; Pankaj Prasoon
Journal:  World J Surg       Date:  2012-10       Impact factor: 3.352

Review 8.  Laparoscopic Splenectomy for Benign Hematological Disorders in Adults: A Systematic Review.

Authors:  Demetrios Moris; Nikoletta Dimitriou; John Griniatsos
Journal:  In Vivo       Date:  2017 May-Jun       Impact factor: 2.155

9.  Should we routinely transfuse platelet for immune thrombocytopenia patients with platelet count less than 10 × 10⁹/L who underwent laparoscopic splenectomy?

Authors:  Yunqiang Cai; Xubao Liu; Bing Peng
Journal:  World J Surg       Date:  2014-09       Impact factor: 3.352

Review 10.  Management of thrombocytopenia due to liver cirrhosis: a review.

Authors:  Hiromitsu Hayashi; Toru Beppu; Ken Shirabe; Yoshihiko Maehara; Hideo Baba
Journal:  World J Gastroenterol       Date:  2014-03-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.